business news in context, analysis with attitude

Published reports suggest that reimportation legislation – which would allow individuals, businesses and municipalities in the US to import less expensive prescription medicines from Canada – is unlikely to be passed by the US Congress before it adjourns this year.

The reason? Despite broad support from both sides of the aisle, there remains considerable resistance to the concept both from the pharmaceutical lobby and the Bush Administration, which says that such a move would allow unsafe drugs into the country.

However, as the federal government drags its feet, both Illinois and Wisconsin have signed deals with a Canadian pharmacy to get prescription medicines shipped in from north of the border. The same Canadian pharmacy already has deals with Springfield, Massachusetts, Portland, Maine, and Burlington, Vermont.
KC's View:
It’ll be interesting to see if this issue arises in tonight’s vice presidential debate or either of the two remaining presidential debates.